PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,108,579 | -42.5% | 1,521,829 | +4.3% | 0.00% | -42.9% |
| Q2 2023 | $59,359,505 | -11.5% | 1,459,540 | +5.4% | 0.01% | -22.2% |
| Q1 2023 | $67,109,277 | +132430.1% | 1,385,410 | +4.4% | 0.01% | +28.6% |
| Q4 2022 | $50,637 | -99.9% | 1,326,624 | +3.7% | 0.01% | -30.0% |
| Q3 2022 | $64,215,000 | +20.2% | 1,279,198 | -4.1% | 0.01% | +25.0% |
| Q2 2022 | $53,420,000 | +10.9% | 1,333,519 | +3.3% | 0.01% | +33.3% |
| Q1 2022 | $48,172,000 | -4.9% | 1,291,139 | +1.5% | 0.01% | 0.0% |
| Q4 2021 | $50,668,000 | +6.5% | 1,272,130 | -0.5% | 0.01% | 0.0% |
| Q3 2021 | $47,577,000 | -11.2% | 1,278,626 | +0.9% | 0.01% | -14.3% |
| Q2 2021 | $53,570,000 | -1.5% | 1,267,339 | +10.3% | 0.01% | -12.5% |
| Q1 2021 | $54,409,000 | -14.6% | 1,149,100 | +10.1% | 0.01% | -27.3% |
| Q4 2020 | $63,724,000 | +39.1% | 1,044,148 | +6.6% | 0.01% | +22.2% |
| Q3 2020 | $45,799,000 | -6.1% | 979,675 | +1.9% | 0.01% | -10.0% |
| Q2 2020 | $48,772,000 | +17.9% | 961,231 | +3.6% | 0.01% | -9.1% |
| Q1 2020 | $41,373,000 | -49.9% | 927,446 | -46.1% | 0.01% | +22.2% |
| Q4 2019 | $82,644,000 | +210.4% | 1,720,698 | +118.6% | 0.01% | +50.0% |
| Q3 2019 | $26,625,000 | -19.4% | 787,269 | +7.2% | 0.01% | -25.0% |
| Q2 2019 | $33,048,000 | +28.9% | 734,417 | +7.8% | 0.01% | +14.3% |
| Q1 2019 | $25,645,000 | -33.7% | 681,348 | -39.5% | 0.01% | +16.7% |
| Q4 2018 | $38,672,000 | +56.5% | 1,126,812 | +114.3% | 0.01% | -14.3% |
| Q3 2018 | $24,712,000 | +64.1% | 525,813 | +17.8% | 0.01% | +40.0% |
| Q2 2018 | $15,060,000 | +52.4% | 446,519 | +22.2% | 0.01% | +66.7% |
| Q1 2018 | $9,885,000 | +88.1% | 365,322 | +15.9% | 0.00% | +50.0% |
| Q4 2017 | $5,256,000 | -27.6% | 315,112 | -13.2% | 0.00% | -33.3% |
| Q3 2017 | $7,263,000 | +36.0% | 363,005 | +24.6% | 0.00% | +50.0% |
| Q2 2017 | $5,340,000 | +100.8% | 291,415 | +7.8% | 0.00% | +100.0% |
| Q1 2017 | $2,659,000 | -6.0% | 270,264 | +4.2% | 0.00% | 0.0% |
| Q4 2016 | $2,829,000 | -11.9% | 259,306 | +13.1% | 0.00% | -50.0% |
| Q3 2016 | $3,211,000 | +102.7% | 229,195 | +1.5% | 0.00% | +100.0% |
| Q2 2016 | $1,584,000 | +9.8% | 225,753 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $1,442,000 | -79.7% | 224,053 | +2.4% | 0.00% | -75.0% |
| Q4 2015 | $7,091,000 | +24.0% | 218,886 | +2.2% | 0.00% | +33.3% |
| Q3 2015 | $5,717,000 | -25.0% | 214,143 | +35.1% | 0.00% | -25.0% |
| Q2 2015 | $7,627,000 | -13.6% | 158,482 | +9.2% | 0.00% | -20.0% |
| Q1 2015 | $8,829,000 | +16.8% | 145,103 | -0.7% | 0.01% | +25.0% |
| Q4 2014 | $7,562,000 | +32.2% | 146,088 | +12.4% | 0.00% | 0.0% |
| Q3 2014 | $5,719,000 | +71.2% | 129,954 | +1.7% | 0.00% | +100.0% |
| Q2 2014 | $3,341,000 | +28.0% | 127,832 | +28.0% | 0.00% | 0.0% |
| Q1 2014 | $2,611,000 | +213.4% | 99,894 | +103.5% | 0.00% | +100.0% |
| Q4 2013 | $833,000 | -19.8% | 49,095 | +1.4% | 0.00% | 0.0% |
| Q3 2013 | $1,039,000 | – | 48,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |